Forbes July 8, 2025
Arthur L. Kellermann

America’s generic drug supply, most of which is manufactured overseas, is not consistently safe. Currently, the website of the U.S. Food and Drug Administration’s Office of Generic Drugs tells a different story.

“The Office of Generic Drugs (OGD) ensures high-quality, affordable generic drugs are available to the American public. Generic drugs account for more than 90 percent of prescriptions filled in the United States. FDA-approved generic drugs have the same high quality, strength, purity and stability as brand-name drugs. The generic manufacturing, packaging, and testing sites used must pass the same quality standards as those of brand-name drugs.”

The second of these statements is true. The other three are not. Generic drugs account for the vast majority of...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Safety
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
Introducing the Sunday Times Tech 100: Life sciences part 1

Share Article